-
Advocacy Spotlight: Sorting Out PrioritiesOvarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.
by Cici Zhang
-
Bill Aims to Improve Childhood Cancer ResearchThe STAR Act passes in the U.S. House of Representatives.
by Brad Jones
-
Forward Look
Breast Density MattersBreast cancer risk factor may be overlooked.
by Kendall K. Morgan
-
Forward Look
More Options for Adolescents in Clinical TrialsNew recommendations support inclusion of teens in adult studies.
by Susan Kreimer
-
Healing Through ArtThe Breast Cancer Art Project encourages breast cancer patients and survivors to produce—and share—art about their cancer experiences.
by Ashley P. Taylor
-
Forward Look
Tackling Drug ResistanceResearchers are studing new ways to keep treatments working longer.
by Stephen Ornes
-
Brain Cancer Patients Make ConnectionsAn app developed for glioblastoma patients allows them to track their symptoms and contribute to research.
by Brad Jones
-
Survivor Profile
The Gift of MusicA self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire.
by Jenny Song
-
Going Off-LabelPhysicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.
by Kate Yandell
-
Q&A
Trial GuideResearcher Tom Marsilje is helping fellow colorectal cancer patients sort through clinical trials.
by Kate Yandell
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
